Phase 4 Thrombocytopenia Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China224 enrolled1 locationNCT04518475
Recruiting
Phase 4
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
ThrombocytopeniaCancer-associated Thrombosis
Tzu-Fei Wang50 enrolled4 locationsNCT05255003
Recruiting
Phase 4
Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study
ITP - Immune Thrombocytopenia
Al-Mustansiriyah University25 enrolled1 locationNCT07133659
Recruiting
Phase 4
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
Thrombocytopenia
The Third People's Hospital of Chengdu55 enrolled1 locationNCT06562738
Recruiting
Phase 4
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment
Fujian Medical University Union Hospital580 enrolled1 locationNCT05520892
Recruiting
Phase 4
Short-course High-dose Prednisone and Dexamethasone in Children With ITP
Immune ThrombocytopeniaChild, OnlyGlucocorticoids
Fujian Medical University Union Hospital608 enrolled1 locationNCT05522465